Home > Boards > US Listed > Biotechs > Agenus (AGEN)

I don't understand why this tanked.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Kongol626 Member Profile
 
Followed By 0
Posts 41
Boards Moderated 0
Alias Born 11/08/17
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2021 7:54:25 PM
Agenus’ Presentations at ASCO 2021 Demonstrate Differentiated Activity of Balstilimab and Provide Clinical Update on AGEN23... GlobeNewswire Inc. - 6/4/2021 9:09:17 AM
Agenus to Participate in Fireside Chat at the Jefferies 2021 Virtual Healthcare Conference GlobeNewswire Inc. - 6/1/2021 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/21/2021 6:14:21 PM
Agenus’ anti-PD-1 antibody shows activity in both PD-L1 positive and PD-L1 negative tumors Seeking Alpha - 5/20/2021 8:04:14 AM
Agenus Presents New Data on Balstilimab and AGEN2373 in ASCO Abstracts GlobeNewswire Inc. - 5/20/2021 7:00:00 AM
Is Agenus Stock Still Worth Buying After Its 20%-Plus Rally? Analyst Weighs In TipRanks - 5/19/2021 4:32:17 PM
Agenus rises 22% on up to $1.5B deal with Bristol-Myers Squibb Seeking Alpha - 5/18/2021 3:41:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/18/2021 7:41:11 AM
Agenus to Host Conference Call to Discuss Global Licensing Agreement with Bristol Myers Squibb for Agenus’ Anti-TIGIT Bispe... GlobeNewswire Inc. - 5/18/2021 7:31:00 AM
Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific Antibody Program GlobeNewswire Inc. - 5/18/2021 7:30:00 AM
Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific Antibody Program Business Wire - 5/18/2021 7:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/10/2021 5:07:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/7/2021 6:06:41 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2021 4:13:25 PM
Agenus shares fall after Q1 topline miss Seeking Alpha - 5/6/2021 9:06:58 AM
Agenus EPS beats by $0.04, misses on revenue Seeking Alpha - 5/6/2021 7:47:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2021 7:45:48 AM
Agenus Corporate Update and First Quarter 2021 Financial Report GlobeNewswire Inc. - 5/6/2021 7:45:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2021 4:04:05 PM
Agenus to Present at the 2021 ASCO Annual Meeting GlobeNewswire Inc. - 4/28/2021 5:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/23/2021 6:35:00 PM
Agenus to Provide Corporate Update and First Quarter 2021 Financial Report GlobeNewswire Inc. - 4/22/2021 4:05:00 PM
Agenus files balstilimab application in U.S. for cervical cancer Seeking Alpha - 4/19/2021 8:59:18 AM
Agenus Submits Balstilimab Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical C... GlobeNewswire Inc. - 4/19/2021 8:30:00 AM
Kongol626   Friday, 03/01/19 03:28:11 PM
Re: None
Post # of 1152 
I don't understand why this tanked.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences